Brinker Capital’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
Brinker Capital's DGX Position: Q2 2020 in Review
Brinker Capital reduced its Quest Diagnostics (DGX) stake by 1.3% in Q2 2020, selling an estimated $20.8K and leaving 14,858 shares worth $1.69M. The position accounts for 0.05% of the portfolio, ranked #343.
Brinker Capital first reported a position in DGX in Q3 2016 and has held it in 16 quarters since. The position peaked at $9.17M in Q1 2019. 749 funds tracked by Wall St. Rank hold DGX as of Q2 2020.
- Brinker Capital held 14,858 shares of Quest Diagnostics worth $1.69M as of Q2 2020.
- Brinker Capital sold 196 Quest Diagnostics shares in Q2 2020, an estimated $20.8K.
- Quest Diagnostics made up 0.05% of Brinker Capital's portfolio in Q2 2020, its #343 holding.
- Brinker Capital first reported a position in Quest Diagnostics in Q3 2016 and has held it in 16 quarters since.
- Brinker Capital's Quest Diagnostics position peaked at $9.17M in Q1 2019.
- 749 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2020.
Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.